3-deazaneplanocin A (Newcastle University/University of Georgia)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name3-deazaneplanocin A (Newcastle University/University of Georgia)
Drug Alias NameDzNepDzNep (Newcastle University/University of Georgia)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 degraders
TargetsHistone-lysine N-methyltransferase EZH2
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Georgia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNewcastle UniversityUniversity Of Georgia
Active IndicationsN/A
Inactive IndicationsLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A